Search

Search results

44 results found

Gang Luo, PhD, Recognized with American Academy of Optometry Award

At the recent American Academy of Optometry annual meeting in Boston, Gang Luo, PhD, Associate Professor of Ophthalmology and Associate Scientist at Schepens Eye Research Institute of Mass Eye and Ear, was honored with the 2021 William Feinbloom Award. This award is presented to an individual who...

Ophthalmology Faculty Receive Faculty Development Awards

Three ophthalmology faculty members were honored last month at the 26th annual celebration for the Eleanor and Miles Shore Faculty Development Awards. These fellowship and distinguished scholar awards support the academic success of junior faculty who are balancing early careers with significant...

OHNS resident Dr. Ryan Bartholomew awarded 2022 NEOS Resident Research Grant

Ryan Bartholomew, MD, a T32 otolaryngology–head and neck surgery (OHNS) resident at Harvard Medical School, has been awarded a 2022 New England Otolaryngological Society (NEOS) Resident Research Grant. Every year, the NEOS awards several research grants to residents at accredited OHNS training...

20220301 Postdoc position in Vakili Lab

Postdoctoral Research Fellow- Cancer Biology Applications are currently being accepted for a postdoctoral fellow to join the laboratory of Khashayar Vakili at Boston Children’s Hospital/Harvard Medical School, Boston, Massachusetts. Our research focuses on liver cancer biology by analyzing patient...

Payel Ganguly

Payel completed her PhD from University of British Columbia, Vancouver where she used Drosophila as a model system to functionalize human gene variants involved in neurodevelopmental disorders. Currently she is a postdoctoral fellow in the Van Vactor and Artavanis lab where she is again using her...

Message from the Editor-in-Chief

Dear Colleagues, Research in gene augmentation and genome editing for the treatment of inherited retinal disorders (IRDs) is thriving. It is estimated that IRDs affect about 200,000- 300,000 people in the United States and 4-6 million people worldwide. Most patients with these conditions become...

Gene Therapy, Gene Editing, and IRDs

Gene-Augmentation Therapy Gene therapy typically refers to gene-augmentation therapy. In this approach, a healthy version of the mutated gene is packaged inside an engineered and nonpathogenic form of adeno-associated virus (AAV), with the virus serving as a vector to carry the gene. AAV does not...

Gene Therapy for Other Ophthalmic Conditions

Advances in the future may include viral vectors, non-viral vectors, and delivery methods that allow treatment of a greater retinal expanse and an expanded approach to technical challenges related to gene size and disease mechanisms. Genetic therapies for non-retinal ophthalmic diseases are also...